Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study

Abstract Background Histologic variants (HV) of urothelial carcinoma (UC-V) and non-urothelial carcinomas (NUC) of the bladder and urinary tract are aggressive malignancies with poor prognosis and limited response to platinum-based chemotherapy. Despite their biological particularities and distinct...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Karim Amrane, Luca Campedel, Fabien Moinard-Butot, Mathilde Gout, Hakim Mahammedi, Mostefa Bennamoun, Tressie Herrmann, Pierre-Etienne Gabriel, Damien Pouessel, Matthieu Roulleaux-Dugage, Constance Thibault, Mathilde Cancel, Aude Flechon, Olivier Huillard, Baptiste Abbar, Delphine Borchiellini, Louis Doublet, Laëtitia Augusto-Pelegrin, Elouen Boughalem, Pierre Cornillon, Clément Dumont, Philippe Barthélémy
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Springer 2026-05-01
Saila:	Cancer Immunology, Immunotherapy
Gaiak:	Immune Checkpoint Blockade Real-world study Advanced urothelial carcinoma Histological variants Squamuous cell carcinoma
Sarrera elektronikoa:	https://doi.org/10.1007/s00262-026-04421-z
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!